Form 4 for BMY Bristol Myers Squibb
Accepted 2023-02-08 00:00:00 ET · period of report 2023-02-06 · accession 0000014272-23-000044 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-08 | 2023-02-06 | BMY | Caforio Giovanni | CEO, Board COB, Dir | S - Sale | $74.65 | -240.0K | 236.1K | -50% | -$17.92M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.10 par value | 2023-02-06 | S | D | 240,000 | $74.65 | 236,104.33 | D | — | — | (F1) The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $74.250 to $75.105, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. |